India’s rapidly growing healthcare sector and large population present significant opportunities for global medical device manufacturers. However, navigating India’s regulatory landscape, particularly the requirements of the Central Drugs Standard Control Organization (CDSCO), is critical for market entry and long-term success. As the national regulatory authority for drugs, medical devices, and cosmetics, CDSCO has taken major steps in recent years to strengthen and streamline its medical device regulatory framework to align with global best practices.

Overview of CDSCO’s Role in Medical Device Regulation

The Central Drugs Standard Control Organization (CDSCO) operates under the Ministry of Health and Family Welfare and serves as India’s principal regulatory body for medical devices. It ensures that medical devices sold in India are safe, effective, and meet quality standards. Its authority covers all aspects of the medical device lifecycle – from manufacturing and import to distribution and post-market surveillance.

Historically, only a limited set of medical devices were regulated as “notified devices.” However, since the implementation of the Medical Devices Rules (MDR), 2017, the regulatory scope has expanded significantly. The CDSCO now requires registration and licensing for a much broader range of medical devices, using a risk-based classification system aligned with international norms.

Medical Device Classification Under CDSCO

Medical devices are categorized into four classes based on their risk profile:

Class A – Low risk (e.g., surgical dressings, thermometers)
Class B – Low to moderate risk (e.g., infusion sets, suction equipment)
Class C – Moderate to high risk (e.g., ventilators, orthopedic implants)
Class D – High risk (e.g., heart valves, pacemakers)

Key Documentation for CDSCO Registration

To demonstrate safety and effectiveness, manufacturers and importers must submit a comprehensive set of documents. These include:

Device Master File (DMF): Detailed technical and manufacturing information about the device.
Plant Master File (PMF): A summary of manufacturing operations, facilities, and quality controls.
Clinical Evaluation Report (CER): A summary of clinical data supporting the safety and performance of the device.
Risk Management Report: Outlines risk analysis conducted under ISO 13485 or equivalent standards.
Performance Evaluation Report (if applicable): Required for diagnostic devices and others needing performance validation.
Quality Management System (QMS) Certificate: Proof of compliance with ISO 13485 or an equivalent standard.
BIS Certification (if applicable): Certain devices must meet Indian Standards established by the Bureau of Indian Standards (BIS).
Labeling Information: Must comply with MDR 2017 labeling rules, including the manufacturer/importer name, batch number, manufacturing and expiry dates, and warnings where applicable.

Failure to provide complete or compliant documentation can result in significant delays or rejection of the application.

Application Process for Medical Device Registration

The CDSCO medical device registration process involves multiple steps. While the complexity depends on the risk class, all applications are submitted online via the Sugam Portal, CDSCO’s e-governance platform.

Application Submission

Form MD-14 is used to apply for manufacturing/import licenses for Class A and B devices.
Form MD-15 is used for Class C and D devices, which require more detailed scrutiny.
The submission must include all required documents, including DMF, PMF, clinical data, QMS certification, and labeling.
A registration fee, which varies depending on the device class and whether it is being manufactured locally or imported, must also be paid at this stage.

Review and Scrutiny

Once submitted, CDSCO reviews the application for completeness and compliance:

For Class A and B devices, the review is relatively straightforward and typically conducted by a notified body or state licensing authority under CDSCO’s oversight.
For Class C and D devices, CDSCO conducts a more thorough technical evaluation, often involving external subject matter experts and the Technical Advisory Committee (TAC). This stage may require clarification or additional documentation from the applicant.

Inspection and Verification

For domestic manufacturers, CDSCO or designated notified bodies may conduct on-site inspections to verify adherence to Good Manufacturing Practices (GMP) and ISO 13485 standards.
For imported devices, the CDSCO may either:
- Rely on inspection reports from recognized foreign regulatory agencies (such as US FDA, EU notified bodies, or TGA), or
- Conduct its own inspection of the foreign manufacturing site, especially for high-risk Class D devices.

Grant of License

Upon successful review and inspection:

A manufacturing or import license is issued:
- Form MD-5 for Class A and B devices
- Form MD-6 for Class C and D devices
The license is valid for five years, after which renewal is required.
Devices are listed in the CDSCO medical device database, and post-market responsibilities (e.g., adverse event reporting, recalls) begin.

CDSCO Submission Timelines

The time required for registration varies based on device class and the specific circumstances of the application.

Class A and B Devices

Typical review and approval timeline: 3 to 6 months
If an inspection is required, add an additional 1 to 2 months

Class C and D Devices

Technical review and TAC consultations can extend the timeline to 6 to 12 months
For high-risk or novel devices, inspections and expert consultations may further increase timelines by 2 to 3 months

Applicants should plan accordingly, as delays can occur if additional data is requested or if inspections are delayed.

Compliance Obligations After Registration

Obtaining a CDSCO license is just the beginning. Manufacturers and importers must remain compliant throughout the lifecycle of the device.

Key post-registration obligations include:

Adverse Event Reporting: As per MDR 2017, license holders must promptly report serious adverse events involving their devices.
Changes to Approved Products: Any significant changes (e.g., design modifications, labeling changes, manufacturing site changes) require prior approval or notification to CDSCO.
Renewal and Updates: Licenses must be renewed every five years. Manufacturers must also update CDSCO on any changes to QMS certifications or regulatory status in other countries.

India’s Growing Role in Global Medical Device Supply Chains

As geopolitical tensions with China rise and China pushes for domestic self-reliance, many Western medical device companies are shifting focus to India, not only as a sales market, but also for sourcing, R&D, and local manufacturing.

The Indian government has supported this trend through initiatives like the National Medical Device Policy (2023) and the Production Linked Incentive scheme, which offer funding to boost local manufacturing. Major companies such as Siemens, Philips, Medtronic, GE, Boston Scientific, and Stryker have expanded operations in India.

India offers low labor costs, a large STEM workforce, and a growing number of medical device parks, making it an increasingly attractive hub for both domestic production and export.

Conclusion

India’s medical device market is one of the fastest-growing in the world, driven by increasing healthcare demand, public and private sector investments, and a shift toward value-based care. For international medical device companies, the potential is substantial, but entering this market requires careful planning, accurate classification, robust documentation, and full compliance with CDSCO’s registration and licensing processes.

Written by: Ames Gross – President and Founder, Pacific Bridge Medical (PBM)

Mr. Gross founded PBM in 1988 and has helped hundreds of medical companies with regulatory and business development issues in Asia. He is recognized nationally and internationally as a leader in the Asian medical markets. Mr. Gross has a BA degree, Phi Beta Kappa, from the University of Pennsylvania and an MBA from Columbia University.